• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Skip to navigation
Close Ad

The Spoon

Daily news and analysis about the food tech revolution

  • Home
  • Podcasts
  • Events
  • Newsletter
  • Connect
    • Custom Events
    • Slack
    • RSS
    • Send us a Tip
  • Advertise
  • Consulting
  • About
The Spoon
  • Home
  • Podcasts
  • Newsletter
  • Events
  • Advertise
  • About

January AI

January 31, 2024

Food as Medicine Platform Foodsmart Expands Reach to 7.4 Million Patients as it Reels in $10M in Fresh Funding

Today, food as medicine and telehealth startup Foodsmart announced an expansion of its “Foodscripts” program and a new round of funding. The company says it will reach up to 7.4 million patients across three major healthcare systems: Advocate Health, Memorial Hermann Health System, Intermountain Health. These healthcare systems, alongside the American College of Cardiology and Glen Tullman’s 62 Ventures, have invested $10 million as part of an expanded Series C investment (now up to $40M) as part of the expansion.

The company is part of the food-as-medicine movement, which encourages healthier eating to create a healthier life overall.  As chronic diseases continue to be a predominant health issue in the United States, there have been calls for our health system to provide better nutritional guidance to patients. The growth in food-as-medicine has come alongside growing usage by at-risk patients of GLP-1 drugs as a reasonably fast way to manage their weight. However, GLP-1 drugs are expensive and often require daily self-administered injections. Foodsmart and other food-as-medicine proponents see “food care” as a better, longer-term, and less costly solution, as well as one that can be paired with initial “jump starter” usage of GLP-1 drugs to get quicker and sustained outcomes.

In an email to The Spoon, Foodsmart outlined the different components of the program expansion:

  1. Extended Reach: The program will be extended to 7.4 million patients across the funding healthcare systems, which the company says represents a substantial increase in its impact and potential to improve health outcomes.
  2. Enhanced Funding: The additional $10 million funding brings the total Series C investment to $40 million.
  3. Strategic Partnerships: Collaborations with healthcare systems and organizations, which Foodsmart says emphasize the importance of integrating nutrition into healthcare and highlight Foodscripts’ potential to transform patient care.
  4. EHR Integration: Foodsmart has developed an Electronic Health Record (EHR) integration, which they say will enable providers to enter and track Foodscripts more easily for insurance purposes.
  5. Upskilling Providers: Foodsmart will start emphasizing upskilling healthcare providers. This involves educating them on the latest scientific data and best practices for addressing the nutritional needs of patients with various chronic diseases.

The growth in offerings within the formalized healthcare community around nutrition guidance comes at a time of increased attention among technology platform providers around personalized nutrition and metabolic health management. Startups like January.AI are providing AI-powered solutions that help those at risk of metabolic disease ways to manage their caloric intake and the impact on their blood glucose levels without having to use a continuous glucose monitor. Other startups like Supergut are tapping into the growing awareness of metabolic health – largely driven by rising awareness of the impact of GLP-1 drugs – by providing over-the-counter supplement approaches that claim to have some of the same benefits as these medications.

Investment in this space has been a countervailing trend to slowing interest among venture investors in plant-based food and other better-for-you offerings, which has been victimized in part by a broader venture slowdown as well as slower-than-expected growth of some of the high-profile, high-fliers in the space, such as Beyond Meat and Impossible Foods.

January 18, 2024

January AI’s New App Uses Generative AI to Predict How Food Will Impact Your Blood Sugar

If you’ve been diagnosed with a metabolic health issue, you might have used a continuous glucose monitor (CGM) at some point to track the impact of your food intake on your blood sugar. However, as of March 2023, only 2.4 million people used a CGM in the U.S., and because of the relatively small adoption rate of this technology, the vast majority of folks with diabetes or who are in danger of metabolic health issues may not have access to real-time insights into what the impact different foods may have on their glucose levels.

January AI aims to change this with its latest innovation: a free app that performs predictive analysis on the impact of various foods on blood sugar. The company, which unveiled its newest tool at CES last week, has developed an AI-powered app that analyzes meal photos and offers users immediate feedback on glucose impacts, macros, and healthier meal alternatives.

January says its app uses generative AI to automatically generate accurate food titles and estimates of ingredients and ingredient quantities within complex meals.

“It uses three kinds of generative AI to tell you your blood sugar response,” said Noosheen Hashemi, CEO of January, speaking at The Spoon’s CES Food Tech Conference last week. “It uses our own generative AI for glucose, and then it uses a vision generative AI to pick what’s in the food, and then it uses that language model to give it a title.”

According to the company, its AI-driven predictions are based on millions of data points, including wearable data, demographic information, and user reports. The company says this approach enables the app to provide personalized glucose level estimates and insights, making metabolic health management more accessible and actionable.

“It’s as simple as scanning a food,” said Hashemi. “You can also scan a barcode. You can also do a search. And we can tell you all the macro, its total calories, how much fiber, protein, fat, and carbs it has. And we can also show your blood sugar.”

According to Hashemi, the company’s platform can be customized and trained for specific users by taking data from a wearable such as a smartwatch, a person’s glucose monitor, or even food logs. With that data, the app can create highly customized predictions around a person’s biomarkers and dietary preferences.

“One out of three people in America has pre-diabetes, and 90% of them don’t know it,” said Hashemi. “And one out of nine people has diabetes, and 20% of those people don’t know it. So blood sugar is something we should all be managing, but we just don’t know that we should.”

Given the increasing popularity of GLP-1 medications, my guess is that more Americans will start to consider how their diet affects their blood sugar in the coming years. And, even if they don’t use a glucose monitor or get a prescription for a medication like Ozempic, increased awareness will push many to use apps like this one to help them better understand how a given food will impact their blood sugar and overall health.

You can hear Hashemi discussing the app and showing a demo in the video below.

January AI CEO Talks About New Generative AI App at CES

Primary Sidebar

Footer

  • About
  • Sponsor the Spoon
  • The Spoon Events
  • Spoon Plus

© 2016–2025 The Spoon. All rights reserved.

  • Facebook
  • Instagram
  • LinkedIn
  • RSS
  • Twitter
  • YouTube
 

Loading Comments...